Global Effervescent Tablet Market By Size, Share, Trend, Growth, and Forecast to 2030

The global effervescent tablet market was valued at approximately USD 5.3 billion in 2022, and experts project that it will increase to approximately USD 8.7 billion by 2030, growing at a compound annual growth rate (CAGR) of approximately 6.5% between 2023 and 2030.

Effervescent Tablet Market: Overview

An effervescent pill is a pharmacological dose form that quickly dissolves in water, releasing carbon dioxide gas and producing a pleasant bubbly, or effervescent, sensation. There are numerous makers of effervescent pills. This type of tablet is widely used because it provides a simple, user-friendly, and convenient shape for administering medications, vitamins, minerals, and other active substances. Tablets are typically made up of a combination of active components, such as medications or nutrients, as well as a number of excipients and a carbon dioxide source. In addition, most pills have a carbon dioxide source. The pill is usually compressed with a solution of citric acid and sodium bicarbonate. When these two chemicals are dissolved in water, they undergo a chemical reaction that results in the formation of carbon dioxide bubbles. This effervescence disperses the tablet's contents throughout the water, making it easier to consume and absorb. One of the reasons effervescent tablets are becoming more popular is that they have the potential to deliver a speedier onset of action than standard tablets or capsules. The effervescence expands the surface area of the tablet and causes it to dissolve faster, allowing the body to absorb the active ingredients in less time.

Furthermore, the bubbly aspect of effervescent tablets may appeal to folks who find it difficult to take regular tablets. Effervescent tablets are often used to deliver a variety of pharmaceuticals such as pain relievers, antacids, cold and flu cures, and nutritional supplements. They are also commonly found in dietary supplements such as vitamin C and multivitamins. This is due to their pleasant flavour and convenience of administration, which all contribute to enhanced absorption and compliance. Growing elderly populations, higher need for dietary supplements, increased levels of innovation and product development, and rising respiratory disease prevalence are just a few of the factors driving growth in the global effervescent tablet market.

Effervescent Tablet Market: Growth Drivers

The rising prevalence of chronic diseases is fueling the market's expansion.

The market for effervescent tablet products is likely to grow in the next years as the prevalence of chronic disorders rises. Chronic difficulties frequently last three months or longer and can deteriorate over time. Chronic diseases also affect a larger population. The most frequent types of chronic illness are cancer, cardiovascular disease, stroke, diabetes, and rheumatoid arthritis. Effervescent tablets are used to treat chronic conditions such as diabetes, cancer, and heart disease. These pills include potent antioxidants that increase blood antioxidant levels and lower the risk of developing chronic diseases.

Effervescent Tablet Market: Segmentation

The effervescent tablet market is segmented into several submarkets based on product, manufacturing technique, indication, application, end user, and geographic location.

The global pharmaceutical and supplement markets are distinguished by product. The market for supplements is predicted to grow at the fastest rate over the forecast period. When effervescent tablets are exposed to water, they dissolve completely and fast. The active chemicals in the solution have higher bioavailability than standard tablets or capsules due to their increased solubility. The effervescence aids in the diffusion of the supplement throughout the liquid, guaranteeing uniform distribution and boosting absorption.

Effervescent Tablet Market: Regional Analysis

North America is expected to dominate the market during the forecast period

North America is expected to dominate the effervescent tablet market during the forecast period. The regional growth is ascribed to various factors such as the growing prevalence of chronic disorders and the presence of major market players. For instance, as per CDC data, in the United States, 1,603,844 new instances of cancer were reported in 2020, and 602,347 cancer-related deaths were recorded. 403 new instances of cancer and 144 cancer-related deaths were recorded for every 100,000 persons. Furthermore, the increasing geriatric population and the growing innovative product launches in the region propel the market revenue.

Effervescent Tablet Market: Competitive Analysis

The global effervescent tablet market is dominated by players like:

Bayer AG
Bristol-Myers Squibb Company
Novartis AG
Pfizer Inc.
Perrigo Company plc
Reckitt Benckiser Group PLC
GSK plc
CHIESI SAS
Hermes Pharma
S. G. Biopharm Pvt. Ltd
Bliss GVS Pharma Limited
Alpex
SCITECH
Vovantis Laboratories
Swisse Wellness PTY LTD
Herbalife International of America Inc.
Nuun
Natur Produkt Zdrovit Sp Z O O
Vitabiotics Ltd
Amerilab Technologies Inc.
HERMES ARZNEIMITTEL
Others.

The global effervescent tablet market is segmented as follows:

By Product

Medication
Supplements
By Methods

Dry Methods
Wet Granulation
By Indication

Pain Management
Diuretics
Gastric Disorders
Respiratory Diseases
Others
By Application

Dental Products
Dietary Supplements
Pharmaceutical
Others
By End User

Hospitals
Specialty Clinics
Homecare
Others
By Region
North America
The U.S.
Canada
Europe
France
The UK
Spain
Germany
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Southeast Asia
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East Africa
GCC
South Africa
Rest of Middle East Africa